1. Home
  2. GSM vs PHAR Comparison

GSM vs PHAR Comparison

Compare GSM & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.19

Market Cap

964.9M

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$17.05

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSM
PHAR
Founded
2015
1988
Country
United Kingdom
Netherlands
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
964.9M
1.1B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
GSM
PHAR
Price
$4.19
$17.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$39.00
AVG Volume (30 Days)
1.3M
17.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.36
$10.04
Revenue Next Year
$17.85
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$3.04
$7.79
52 Week High
$5.74
$21.34

Technical Indicators

Market Signals
Indicator
GSM
PHAR
Relative Strength Index (RSI) 45.52 60.59
Support Level $4.10 $17.25
Resistance Level $4.54 $17.60
Average True Range (ATR) 0.22 0.64
MACD 0.03 0.16
Stochastic Oscillator 56.25 97.43

Price Performance

Historical Comparison
GSM
PHAR

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: